Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trialsJames A. Simon, Michael C. Snabes, Elizabeth A. Stewart et al.|F&S Reports|2024Cited by 1
Elagolix With Add-Back Rapidly Improves Nonbleeding Symptoms in Individuals With Fibroid-Associated Heavy Menstrual Bleeding [ID: 1368052]James A. Simon, Brett Pinsky, Moming Li et al.|Obstetrics and Gynecology|2023Cited by 0